• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. TRUE FLOW DILATATION CATHETER; VALVULOPLASTY BALLOON CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. TRUE FLOW DILATATION CATHETER; VALVULOPLASTY BALLOON CATHETER Back to Search Results
Catalog Number UNK TRUE FLOW
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Intimal Dissection (1333); Myocardial Infarction (1969); Renal Failure (2041)
Event Date 10/17/2018
Event Type  Injury  
Manufacturer Narrative
As the lot number for the device was not provided, a manufacturing review could not be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.Journal article citation: schneeberger, y., schaefer, a., schofer, n., silaschi, m., deuschl, f., blankenberg, s., ¿ conradi, l.(2018, october 18).Transcatheter aortic valve implantation utilizing a non-occlusive balloon for predilatation.Retrieved from https://www.Sciencedirect.Com/science/article/pii/s0167527318330791.
 
Event Description
It was reported in an article from the international journal of cardiology, titled " transcatheter aortic valve implantation utilizing a non-occlusive balloon for predilatation " that balloon aortic valvuloplasty (bav) was performed preceding transcatheter aortic valve implantation (tavi) in 27 patients.In one patient periprocedural myocardial infarction became apparent due to dissection of the left anterior descending artery.Acute renal failure necessitating renal replacement and major access site complications occurred in one patient respectively.A postprocedural permanent pacemaker (ppm) implantation due to atrioventricular blockade (avb) was indicated in 2 patients.The status of the patients was not provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRUE FLOW DILATATION CATHETER
Type of Device
VALVULOPLASTY BALLOON CATHETER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer Contact
judith ludwig
1415 w. 3rd street
tempe, AZ 85281
4803032689
MDR Report Key9485041
MDR Text Key174556501
Report Number2020394-2019-05661
Device Sequence Number1
Product Code OZT
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K172932
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 12/17/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/17/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK TRUE FLOW
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Date Manufacturer Received11/20/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-